Transaction · 0001628280-26-065462

Douglass Brian Robb

Douglass Brian Robb, CPO, reported a transaction classified as grant at REPLIGEN CORP involving 700.000000 shares for an estimated $0.00. Reported holdings after the transaction were 8685.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACPO
RGENREPLIGEN CORP
Filing timeOct 08
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$167.22
Pre-filing
1mo ago +0.2%1w ago +16.4%1d ago +13.3%
Returns since
7d30d90d180d1y

RGEN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RGEN since 2026-10-08Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001628280-26-065462
Common Stock
Transaction date
Oct 06, 2026
Filed Oct 08, 2026, 08:40 PM · 2d delay
Shares
700 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
8.68k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF PRODUCT OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Mr. Douglass was awarded 700 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units ve…

  2. F2

    225 shares will vest on each of October 6, 2027, October 6, 2028, and October 6, 2029.

Original filing · 0001628280-26-065462
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RGEN